Activated inflammatory T cells correlate with lesion size in human cutaneous leishmaniasis

Oliveira-Neto, 1997, A low-dose antimony treatment in 159 patients with American cutaneous leishmaniasis: extensive follow-up studies (up to 10 years), Am J Trop Med Hyg, 57, 651, 10.4269/ajtmh.1997.57.651

Liew, 1999, Immune effector mechanism in parasitic infections, Immunol Lett, 65, 101, 10.1016/S0165-2478(98)00131-X

Marovich, 2000, IL-12p70 production by Leishmania major-harboring human dendritic cells is a CD40/CD40 ligand-dependent process, J Immunol, 164, 5858, 10.4049/jimmunol.164.11.5858

Bacellar, 2002, Up-regulation of Th1-type responses in mucosal leishmaniasis patients, Infect Immun, 70, 6734, 10.1128/IAI.70.12.6734-6740.2002

Antonelli, 2004, Antigen specific correlations of cellular immune responses in human leishmaniasis suggests mechanisms for immunoregulation, Clin Exp Immunol, 136, 341, 10.1111/j.1365-2249.2004.02426.x

Guedes C, Cuce L, Furtado T. Avaliacao imunologica e histopatologica da reacao de Montenegro. In: An Brasil de Dermatologia. 66 ed.; 1990, p. 34S–40S.

Mayrink, 1985, An experimental vaccine against American dermal leishmaniasis: experience in the State of Espirito Santo, Brazil, Ann Trop Med Parasitol, 79, 259, 10.1080/00034983.1985.11811917

Bottrel, 2001, Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis, Infect Immun, 69, 3232, 10.1128/IAI.69.5.3232-3239.2001

Mayrink, 1989, Histological observations on Montenegro's reaction in man, Rev Inst Med Trop Sao Paulo, 31, 256, 10.1590/S0036-46651989000400008

Armijos, 1997, The epidemiology of cutaneous leishmaniasis in subtropical Ecuador, Trop Med Int Health, 2, 140, 10.1046/j.1365-3156.1997.d01-236.x

Trujillo, 2002, Endemically exposed asymptomatic individuals show no increase in the specific Leishmania (Viannia) panamensis-Th1 immune response in comparison to patients with localized cutaneous leishmaniasis, Parasite Immunol, 24, 455, 10.1046/j.1365-3024.2002.00488.x

Da-Cruz, 1994, Leishmania-reactive CD4+ and CD8+ T cells associated with cure of human cutaneous leishmaniasis, Infect Immun, 62, 2614, 10.1128/IAI.62.6.2614-2618.1994

Belkaid, 2002, CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity, Nature, 420, 502, 10.1038/nature01152

Rocha, 1999, Down-regulation of Th1 type of response in early human American cutaneous leishmaniasis, J Infect Dis, 180, 1731, 10.1086/315071

Bacellar, 2002, Up-regulation of Th1-type responses in mucosal leishmaniasis patients, Infect Immun, 70, 6734, 10.1128/IAI.70.12.6734-6740.2002

Wei, 1999, Altered immune responses and susceptibility to Leishmania major and Staphylococcus aureus infection in IL-18-deficient mice, J Immunol, 163, 2821, 10.4049/jimmunol.163.5.2821